SECUADO is a Transdermal Film, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Noven Therapeutics, Llc. The primary component is Asenapine.
Product ID | 68968-0174_584854cb-d9a5-44e0-adaa-50ebbad1c6e7 |
NDC | 68968-0174 |
Product Type | Human Prescription Drug |
Proprietary Name | SECUADO |
Generic Name | Asenapine |
Dosage Form | Film, Extended Release |
Route of Administration | TRANSDERMAL |
Marketing Start Date | 2020-02-12 |
Marketing Category | NDA / NDA |
Application Number | NDA212268 |
Labeler Name | Noven Therapeutics, LLC |
Substance Name | ASENAPINE |
Active Ingredient Strength | 8 mg/d |
Pharm Classes | Atypical Antipsychotic [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2020-02-12 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA212268 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2020-02-12 |
Ingredient | Strength |
---|---|
ASENAPINE | 7.6 mg/d |
NDC | Brand Name | Generic Name |
---|---|---|
68968-0172 | SECUADO | ASENAPINE |
68968-0173 | SECUADO | ASENAPINE |
68968-0174 | SECUADO | ASENAPINE |
42794-016 | ASENAPINE | ASENAPINE |
42794-017 | ASENAPINE | ASENAPINE |
46708-198 | Asenapine | Asenapine |
46708-199 | Asenapine | Asenapine |
46708-544 | Asenapine | Asenapine |
62332-198 | Asenapine | Asenapine |
62332-199 | Asenapine | Asenapine |
62332-544 | Asenapine | Asenapine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
SECUADO 87659437 5646398 Live/Registered |
HISAMITSU PHARMACEUTICAL CO., INC. 2017-10-25 |